Status:
COMPLETED
Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Cytomegalovirus Infection
Preterm Infants
Eligibility:
All Genders
23-40 years
Phase:
NA
Brief Summary
To evaluate, in a prospective multicenter study, ultrashort-term heat inactivation for the prevention of Cytomegalovirus (CMV) transmission in preterm infants (\<32 weeks gestational age or \<1500 g b...
Eligibility Criteria
Inclusion
- \<32 Weeks or GA or \<1500g BW
- mother CMV IgG positive
- breast milk feeding
Exclusion
- parents disagree
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01178905
Start Date
August 1 2010
Last Update
April 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuebingen University Hospital
Tübingen, Germany, 72070